Hideo Saji

Publication Activity (10 Years)

Years Active: 2014-2019
Publications (10 Years): 6

Top Topics

High Throughput

Fluorescence Imaging

Cognitive Decline

Top Venues

Molecular pharmaceutics

TheScientificWorldJournal

ACS chemical neuroscience

Bioconjugate chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Shimpei Iikuni, Keiichi Tanimura, Hiroyuki Watanabe, Yoichi Shimizu, Hideo Saji, Masahiro Ono
Development of the 99mTc-Hydroxamamide Complex as a Probe Targeting Carbonic Anhydrase IX. Molecular pharmaceutics 16 (4) (2019)
Ryoko Kawai, Mitsugu Araki, Masashi Yoshimura, Narutoshi Kamiya, Masahiro Ono, Hideo Saji, Yasushi Okuno
Core Binding Site of a Thioflavin-T-Derived Imaging Probe on Amyloid β Fibrils Predicted by Computational Methods. ACS chemical neuroscience 9 (5) (2018)
Kohei Sano, Yuko Kanada, Katsushi Takahashi, Ning Ding, Kengo Kanazaki, Takahiro Mukai, Masahiro Ono, Hideo Saji
Enhanced Delivery of Radiolabeled Polyoxazoline into Tumors via Self-Aggregation under Hyperthermic Conditions. Molecular pharmaceutics 15 (9) (2018)
Hiroyuki Watanabe, Masashi Yoshimura, Kohei Sano, Yoichi Shimizu, Sho Kaide, Yuji Nakamoto, Kaori Togashi, Masahiro Ono, Hideo Saji
Characterization of Novel 18F-Labeled Phenoxymethylpyridine Derivatives as Amylin Imaging Probes. Molecular pharmaceutics 15 (12) (2018)
Kohei Sano, Manami Ohashi, Kengo Kanazaki, Akira Makino, Ning Ding, Jun Deguchi, Yuko Kanada, Masahiro Ono, Hideo Saji
Indocyanine Green-Labeled Polysarcosine for in Vivo Photoacoustic Tumor Imaging. Bioconjugate chemistry 28 (4) (2017)
Hiroyuki Watanabe, Masahiro Ono, Taisuke Ariyoshi, Rikako Katayanagi, Hideo Saji
Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of β-Amyloid and α-Synuclein Aggregates. ACS chemical neuroscience 8 (8) (2017)
Hiroyuki Watanabe, Masahiro Ono, Hideo Saji
Novel PET/SPECT probes for imaging of tau in Alzheimer's disease. TheScientificWorldJournal 2015 (2015)
Masashi Ueda, Hideo Saji
Radiolabeled probes targeting hypoxia-inducible factor-1-active tumor microenvironments. TheScientificWorldJournal 2014 (2014)